SEC Form 4 · accession 0001144204-17-062470
Ensysce Biosciences, Inc. · ENSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
HG Vora Capital Management, LLC
10% Owner
Period of report
Dec 5, 2017
Accepted (ET)
Dec 5, 2017 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 5, 2017 | J | 718,750 | $0.00 | D | 2,837,500 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As contemplated by the securities subscription agreement between HG Vora Special Opportunities Master Fund, Ltd. ("HG Vora Special Opportunities") and the Company, 718,750 shares held by HG Vora Special Opportunities were forfeited upon consummation of the Company's initial public offering for no consideration.
- F2Includes 375,000 shares beneficially owned by HG Vora Capital Management, LLC ("HG Vora Capital") that are subject to forfeiture to the extent the underwriters' overallotment option in the Company's initial public offering is not fully exercised.
- F3Securities owned directly by HG Vora Special Opportunities. HG Vora Capital is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment entities. HG Vora Capital, as investment manager of HG Vora Special Opportunities, may be deemed to beneficially own the securities owned directly by HG Vora Special Opportunities.